CPhI Online is the largest global marketplace in the pharma ingredients industry
About GAP S.A.
GAP is vertically integrated Greek pharmaceutical
company operating under EUGMP HACCP from 1949.
GAP operates in the following business units:
1. Softgel capsules Contract Manufacture (Rx, OTC, hormonal, food supplements)
2. Development, manufacture of innovative Generic formulations (ex. Tafalafil soft caps)
3. Development, manufacture and promotion of Nutraceuticals, under our EVIOL brand or under private label.
2015On CPhI since
250 - 499Employees
CPhI Worldwide 2021
Fiera Milano, Milan, Italy
Products from GAP S.A.
GAP is developing Apixaban tbs as a Generic and will be offerered in eCTD dossier.Product is offered for Licensing Out.
Form: film coated tablets
Indications:Prevention of stroke and systemic embolism.Prevention & treatment of deep vein thrombosis and pulmonary embolism
Prevention of venous thromboembolic events
500 mg / 400 IU
1000 mg / 800 IU
Prevention and treatment of calcium and vitamin D deficiency & osteoporosis treatment
Pharmaceutical Form: Soft gelatin caps
800IU, 1.000IU, 3.200IU, 20.000IU, 25.000IU, 50.000IU
Prevention & Treatment of vitamin deficiency.
For treatment of certain bone conditions.
Helps to absorp calcium & enhances bones formation
GAP offer its own brand for Food Supplements for Distribution or Pvt LabelOur formulas developed are ALL based on EFSA claims and cover many therapeutical categories: (ex. Mental Health, Sleep Disorders, Boosting Imune System etc)
For full range please refer of the formulas we offer please go to https://www.eviol.gr/en/
GAP specialises in innovative generics. GAP has developed TADALAFIL in soft caps offering unique marketing opportunities compared to standard generics in tablets.
Indications:Genito-urinary System Erectile dysfunction
Only 5 mg: benign prostatic dysfunction
Only 20 mg: treat pulmonary arterial hypertension
GAP is offering for out licence ISOTRETINOIN soft caps 5-10-20-40mg with the most updated BE study (2018)
GAP manufacturers per year over 250 milion caps of Isotretinoin Product is offered for licensing or contract manufacture agreement
GAP specializes in soft caps technology since the mid 70s and has developed many products in soft capsules.With its cutting edge equipment serves as a CMO to numerous pharma companies in EU.
GAP as the capability to encapsulate under EuGMP, HACCP and Saudi FDA:
- pharma (Rx, hormonal, high potent, cytostatic and OTC),
- food supplements (extracts, oils and suspensions) and
- cosmetics for topical use
GAP S.A. Resources
Position your company at the heart of the global Pharma industry with a CPhI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPhI events
An easy-to-use platform with a detailed dashboard showing your leads and performance